Genscript Biotech (HK:1548) has released an update.
Genscript Biotech Corporation has announced the issuance of 244,121 Restricted Shares to select employees as part of the 2021 RSA Scheme, with the shares set to vest over a three-year period starting August 31, 2025. The grant is motivated by performance targets and subject to clawback provisions, aiming to align employees’ interests with corporate objectives without requiring financial assistance or shareholder approval.
For further insights into HK:1548 stock, check out TipRanks’ Stock Analysis page.
